Dupixent appears to increase asthma control among poorly controlled patients
from Pharmacy Practice News
When added to standard therapies, dupilumab (Dupixent, Sanofi/Regeneron) reduced severe asthma exacerbations and improved lung function, according to a phase 3 study in a broad population of patients with uncontrolled, persistent asthma.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063